Search Results for: us stem cell

Live Blogging #GeneEditSummit Day 2 Post #1: Governance of human gene editing

Barbara-J.-Evans

Now we have an interesting panel starting on questions of governance on human gene editing. This will focus on institutional and national levels of governance. Pilar N. Ossorio, University of Wisconsin, Madison, and Morgridge Institute for Research, is introducing the panel. Key question: how should emerging technologies being governed? Jonathan Kimmelman, from McGill, was the first […]

Live Blogging #GeneEditSummit Day 2 Post #1: Governance of human gene editing Read More »

Live Blogging #GeneEditSummit Day 1 Post #3: human germline modification

Robin-Lovell-Badge-Peter-Braude-George-Church

The post-lunch session is “Applications of Gene Editing Technology: Human Germline Modification”. Prior to hearing it I’m curious how cautious or gung-ho the speakers will be, or if their gestalt will be one of balance in the middle somewhere. Robin Lovell-Badge, The Francis Crick Institute, was the moderator of this session. He said, “We’d be

Live Blogging #GeneEditSummit Day 1 Post #3: human germline modification Read More »

Live Blogging #GeneEditSummit Day 1 Post #2: State of the Science, #CRISPR

Human-gene-editing-science-session-small

Now we hear from the scientists on the front lines of CRISPR, covered in this post #2 of the Human Gene Editing Meeting. You can read Post #1 here. Jennifer Doudna starts off the big human gene editing science session on the current state of the human gene editing science and CRISPR. She gave an

Live Blogging #GeneEditSummit Day 1 Post #2: State of the Science, #CRISPR Read More »

FDA approves 1st GM animal (fast-growing salmon) to eat

AquaAdvantage-Salmon

After a seemingly endless period of review, the FDA has approved the genetically modified (GM) AquaBounty salmon for sale and consumption. Update: You might find my interview with George Church on CRISPR and gene modification interesting. I don’t see any particular reason to think that this GM fish as a food would pose any significant

FDA approves 1st GM animal (fast-growing salmon) to eat Read More »

Ocata bought by Astellas of Japan: initial perspectives on end of an era

Astellas

Bombshell news in the stem cell field as Ocata Therapeutics (OCAT; formerly Advanced Cell Technology or ACT) is reportedly to be acquired by Astellas Pharma, Inc. The offer for purchase of OCAT will be $8.50/share or almost $380 million. For more details see this detailed PDF from Astellas. This quote on the deal form Ocata: “Paul

Ocata bought by Astellas of Japan: initial perspectives on end of an era Read More »

GMO Sapiens book teaser: time to talk frankly on human genetic modification

GMO-Sapiens-Book-Cover

I’ve written a new book on human genetic modification. This is my second book as the first one was Stem Cells: An Insider’s Guide, which is currently the top stem cell book on Amazon. The new book is called GMO Sapiens: The Life-Changing Science of Designer Babies.  You can pre-order it here at Amazon or over here at my publisher’s

GMO Sapiens book teaser: time to talk frankly on human genetic modification Read More »

Tick Tock Genetic Clock: How soon until first DIY CRISPR of self?

I just did a blog post today on the striking story of someone doing DIY CRISPR gene therapy on themselves. A question came to mind. How long until someone does a DIY attempt to CRISPR themselves? In the DIY gene therapy story, the person was injected with so-called “gain-of-function” viruses to try to reap health

Tick Tock Genetic Clock: How soon until first DIY CRISPR of self? Read More »

Weekend science reading: fantastic found links including on CIRM

glioblastomaWiki

David Jensen reports on the future of CIRM as a “beautiful machine”. CIRM funds brain cancer research in a big way: Funding a clinical trial for deadly cancer is a no brainer. Glioblastoma is a fatal tumor that needs new clinical approaches so this is exciting. One of the goals of my lab is to find new

Weekend science reading: fantastic found links including on CIRM Read More »